NCT04469842 - Early Use of Long-acting Tacrolimus in Lung Transplant Recipients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Lung Transplant; Complications

Interventions

DRUG

Tacrolimus Extended Release Oral Tablet [Envarsus]

Immunosuppression regimen with Tacrolimus Extended Release as the backbone.

DRUG

Tacrolimus

Standard Immunosuppression regimen with Intermediate-Release Tacrolimus.

DRUG

Mycophenolate Mofetil Hydrochloride

Standard immunosuppression of the anti-proliferative class.

DRUG

Prednisone

Standard immunosuppression (corticosteroid class).

DRUG

Azathioprine

Standard immunosuppression of the anti-proliferative class.

Trial Locations (1)

RECRUITING

Vanderbilt University Medical Center, Nashville